Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Phylogica Announces Results of Annual General Meeting (ASX:PYC)

PERTH, Australia, 24th November 2017: Phylogica Limited (ASX:PYC) (Phylogica or the Company), pursuant to ASX Listing Rule 3.12.2, advises that all resolutions contained in the Notice of Meeting dated...read more

Phylogica Announces Professor Paul Watt Joins Scientific Advisory Board (ASX:PYC)

PERTH, Australia, 21 November 2017: Phylogica Limited (PYC or the Company) announces that Professor Paul Watt has advised the Board that he will not stand for re-election as a director of Phylogica at...read more

Phylogica, Company Presentation - BIO Europe November 2017 (ASX:PYC)

Creating better drugs through revolutionary intracellular therapeutics Who are we? Biotech platform technology that enhances a highly potent class of biologic drugs What do we do? Expand t...read more

Phylogica Limited, Appendix 4G (ASX:PYC)

Key to Disclosures Corporate Governance Council Principles and Recommendations Financial year ended: 30 June 2017 For further information please download PDF attached:

Phylogica Limited, Corporate Governance Statement – 30th June 2017 (ASX:PYC)

ASX Corporate Governance Council Principles and Recommendations Our Company has adopted comprehensive systems of control and accountability as the basis for the administration of corporate governan...read more

Phylogica, Annual Report 2017 (ASX:PYC)

CONTENTS - Chief Executive Officer’s Letter to Shareholders - Directors’ Report - Auditor’s Independence Declaration - Consolidated Statement of Profit & Loss and Oth...read more

Phylogica Announces Operational Update and Conference Call - September Quarter (ASX:PYC)

PERTH, Australia, 25th October 2017: Phylogica Limited (ASX:PYC) (Phylogica or the Company), developer of a leading intracellular drug delivery platform technology, is pleased to update shareholders o...read more

Phylogica Announces Establishment and Appointments to Scientific Advisory Board (ASX:PYC)

Phylogica Limited, Notice of Initial Substantial Holder (ASX:PYC)

Form 603 Anthony Barton & Associates To view Notice please download PDF attached:

Phylogica Announces New Delivery Vehicles Show Improved Performance Inside Cells (ASX:PYC)

PERTH, Australia, 5th September 2017: Phylogica Limited (ASX:PYC) (Phylogica or the Company), developer of a leading intracellular drug delivery platform technology, is pleased to provide an update on...read more

Phylogica Announces US Patent Granted for Peptides Entering Brain Cells (ASX:PYC)

PERTH, Australia, 4th October 2017: Phylogica Limited (ASX:PYC) (Phylogica or the Company), developer of a leading intracellular drug delivery platform technology, is pleased to announce it has been g...read more

Phylogica Limited, Euroz: Speculative Buy (ASX:PYC)

Company Update Investment Case PYC continues to make steady scientic progress in relation to improving the potency and efficacy of their core Functional Penetrating Peptide (FPP) candidates. The...read more

Phylogica Announces Appointment of Non-Executive Director (ASX:PYC)

PERTH, Australia, 23rd October 2017: Phylogica Limited (ASX:PYC) (Phylogica or the Company), developer of a leading intracellular drug delivery platform technology, is pleased to announce the appointm...read more

Phylogica, Shareholder Update (ASX:PYC)

Perth, Australia: 16 May 2014 – Leading peptide drug discovery company Phylogica Ltd (ASX:PYC, XETRA:PH7) provides this update to shareholders covering: Janssen Commercial Disc...read more

Phylogica, Shareholder Update (ASX:PYC)

Perth, Australia: 7th April 2014 – Leading peptide drug discovery company Phylogica Ltd (ASX:PYC, XETRA:PH7) provides this update to shareholders covering: - Capital Rais...read more

Viewing: 46 - 60 of 116 Previous | Next